Kejie Li

Kejie Li is an accomplished professional in the field of computational biology, currently serving as the Secretary General and Executive Council Member for the Sino-American Pharmaceutical Professionals Association–New England/Boston (SAPA-NE) and the Sino-American Pharmaceutical Professionals Association (SAPA). Kejie holds positions as Sr. Director of Computational Biology at Triveni Bio and Co-Founder at ShengJie Inc. Previously, Kejie was the Head of Computational Biology at Modify Therapeutics and Biogen, where responsibilities included therapeutic program support and developing bioinformatics pipelines. Education includes a PhD in Bioinformatics and Computational Biology from Purdue University, an MS in Bioinformatics from Wageningen University & Research, and a BS in Biological Sciences from Sichuan University, complemented by significant research experience at the Broad Institute and extensive training in bioinformatics and systems biology.